Harvey Dyer

Stay on: CalAmp Corp. (NASDAQ:CAMP), Exelon Corporation (NYSE:EXC), Hewlett-Packard Company (NYSE:HPQ), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), QUALCOMM, Inc. (NASDAQ:QCOM)

CalAmp (NASDAQ: CAMP), reported results for its third quarter ended November 30, 2014. Consolidated third quarter revenue up 7% sequentially to $63.2 million and essentially flat year over year. CalAmp Corp. (NASDAQ:CAMP) belongs to Technology sector. Its net profit margin is 5.50% and weekly performance is -9.77%. On last trading day company shares ended up…

Read More

Stocks on the move: Occidental Petroleum Corporation (NYSE:OXY), Regions Financial (NYSE:RF), IDEX Corporation (NYSE:IEX), The ADT Corporation (NYSE:ADT), NorthStar Realty Finance (NYSE:NRF)

Occidental Petroleum (NYSE:OXY) Director Edward P. Djerejian sold 20,000 shares of the stock on the open market in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $77.50, for a total transaction of $1,550,000.00. Following the sale, the director now directly owns 31,744 shares in the company,…

Read More

Investors Are Eying: Petroleo Brasileiro Petrobras (NYSE:PBR-A), Blucora, Inc. (NASDAQ:BCOR), Shire PLC (NASDAQ:SHPG), Baidu Inc (ADR) (NASDAQ:BIDU), Fifth Street Finance Corp. (NASDAQ:FSC)

Analysts at Credit Suisse assumed coverage on shares of Petroleo Brasileiro Petrobras SA (NYSE:PBR) in a research report issued to clients and investors on Monday. The firm set a “neutral” rating and a $7.30 price target on the stock. Credit Suisse’s target price suggests a potential upside of 16.61% from the stock’s previous close. Petroleo…

Read More

Best Stocks: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), JetBlue Airways Corporation (NASDAQ:JBLU), First Midwest Bancorp Inc. (NASDAQ:FMBI), Prothena Corporation plc (NASDAQ:PRTA), RCI Hospitality (NASDAQ:RICK)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 297,968 shares at the public offering price of $110.75 per share. The exercise of the over-allotment option brought the total number of shares…

Read More